Jing Marantz
Fortune : 6 M $ au 31/05/2026
Fortune : 6 M $ au 31/05/2026
Le Dr Jing L. Marantz est vice-présidente principale des affaires médicales chez Acceleron Pharma, Inc. Elle est membre du conseil d'administration de Krystal Biotech, Inc. Auparavant, le Dr Marantz a été employée en tant que responsable des affaires médicales et vice-présidente principale chez Alnylam Pharmaceuticals, Inc, vice-présidente des affaires médicales chez ARIAD Pharmaceuticals, Inc, et vice-présidente des affaires médicales mondiales chez Alexion Pharmaceuticals, Inc. Elle a obtenu un MBA à la Haas School of Business, un doctorat au Tongji Medical College de la Huazhong University of Sci & Tech et un doctorat à la Medical University of South Carolina.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/02/2026 | 126 012 ( 0,11 % ) | 6 M $ | 31/05/2026 | |
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Directeur/Membre du Conseil | 07/12/2021 |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur Technique/Scientifique/R&D | 09/11/2022 |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Directeur/Membre du Conseil | - |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Directeur/Membre du Conseil | 18/01/2022 |
| ACCELERON PHARMA INC. | Directeur Technique/Scientifique/R&D | 01/11/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2020 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2018 |
| ARIAD PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Medical University of South Carolina
Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national